Tuberculosis News and Research

Latest Tuberculosis News and Research

Therapeutic equivalent to replace penicillin

Antibiotics are among the greatest achievements of medical science. But lately the former multi-purpose weapon fails in the battle against infectious diseases. Bacteria are increasingly developing resistance to antibiotics. Researchers have now found a therapeutic equivalent which could replace penicillin and related phamaceuticals.

8 Jun 2011

Stop TB partnership releases 5 TB prevention steps

Ahead of the U.N. High Level Meeting on AIDS, the Stop TB Partnership released five guidelines aimed at preventing tuberculosis, which results in one in four AIDS-related deaths, the U.N. News Centre writes.

8 Jun 2011

Global Fund's transparency is essential and saves lives

In the Huffington Post, Michel Kazatchkine, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, discusses the Global Fund's latest report on its investigation of its grants in Mali.

8 Jun 2011

International coalition launches common platform to end AIDS epidemic

An international coalition of scientists and activists today launched a common platform for ending the AIDS epidemic. Thirty years into the epidemic, as world leaders come together at the United Nations to recommit to a global AIDS response, the broad-based international coalition issued a statement calling for world leaders to support a rational, evidence-based approach to responding to AIDS.

8 Jun 2011

Former Malian health minister indicted in case about misuse of global fund donations

Oumar Ibrahim Toure, a former Malian health minister, "has been indicted for his role over the misuse of donor funds to fight malaria and tuberculosis in the poor West African nation, Mali's supreme court said in a statement" on Thursday, Reuters reports.

7 Jun 2011

International drug policy panel calls for legalization of some drugs, de-criminalizing drug use

The Global Commission on Drug Policy - a panel that includes former U.N. Secretary-General Kofi Annan, Global Fund to Fight AIDS, Tuberculosis and Malaria Executive Director Michel Kazatchkine, and several other current and former world leaders - has released a report calling for "the legalization of some types of drugs and an end to the criminalization of drug users," The Voice of Russia reports.

4 Jun 2011

Political engagement with China influences involvement in health

After discussing the Global Fund to Fight AIDS, Tuberculosis and Malaria's decision to freeze grant payments to China, Yanzhong Huang, a senior fellow for global health at the Council on Foreign Relations, writes on the council's "Asia Unbound" blog, "In order to encourage the participation of China's civil society groups in global health, it is important to allay the fears of Chinese leaders.

4 Jun 2011

Mimicry allows bacteria to evade host's defense responses

Deadly bacteria may be evolving antibiotic resistance by mimicking human proteins, according to a new study by the Translational Genomics Research Institute (TGen).

3 Jun 2011

Opinion: Integrate NTD, HIV, TB and malaria programs

In a New England Journal of Medicine opinion piece, Peter Hotez of the Sabin Vaccine Institute and colleagues, including Jeffrey Sachs of the Earth Institute of Columbia University, outline how integrating treatment of neglected tropical diseases (NTD) into HIV/AIDS, tuberculosis and malaria control efforts could speed up progress toward attaining the sixth Millennium Development Goal.

3 Jun 2011

New Kaiser Family Foundation tool shows which global health interventions are working

Today, the Kaiser Family Foundation unveiled an innovative, online tool that allows users to learn quickly and easily about which global health interventions work. The Global Health Intervention Review (GHIR) compiles the latest information on the efficacy of key global health interventions, including the strength of the evidence, and presents the information in a variety of accessible formats. Users can view a comprehensive overview and a key findings table.

2 Jun 2011

Experts to present latest information on paediatric infectious diseases at ESPID 2011

The Annual ESPID Meeting has become the world's largest meeting in the field of Paediatric Infectious Diseases (PID): it provides the latest information on the number one threat to global child health.

1 Jun 2011

Media examine funding for HIV/AIDS as disease turns 30

"As the war on AIDS heads into its fourth decade, the need for funds is spiralling relentlessly higher, prompting a quest for new resources from consumer levies to contributions from developing giants," Agence France-Presse/France 24 reports (5/30).

1 Jun 2011

AIDS epidemic turns 30

It is 30 years since the beginning of the AIDS epidemic. It was fatal then but has now become a treatable, if still incurable, chronic illness. AIDS therapy now has tools that prolong the lives of people infected with the virus and prevent others from acquiring it. They range from antiretroviral therapy (ART), to circumcision and campaigns to reduce promiscuity. On the horizon are gels and pills that protect against infection during intercourse. Even the outlook for an AIDS vaccine is no longer as bleak as it used to be.

31 May 2011

Novartis employees to do volunteer work for non-profit groups during 15th annual Community Partnership Day

Some 200 employees of Novartis Pharmaceuticals Canada Inc. will again this year be helping out with cleaning, painting and various other chores and activities at 15 Montreal-area organizations as part of their 15th annual Community Partnership Day, during which they leave their offices for the day to do volunteer work for non-profit groups. It is part of a global effort by Novartis employees that involves 20,000 employees in 55 countries.

30 May 2011

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

UCB today announced data which showed that the addition of Cimzia to current therapy was associated with a rapid and consistent clinical response in a diverse group of rheumatoid arthritis (RA) patients.

30 May 2011

Nature special issue focuses on vaccines

The May 26 issue of Nature explores vaccines, which the journal says "are responsible for some of the world's greatest public health triumphs." Though new vaccines for deadly diseases have been developed in the past 10 years, and more are in development, "funding is tight, and unfounded doubts about the safety of vaccines persist." The issue features stories on polio, measles, HIV/AIDS, tuberculosis and malaria, as well as issues surrounding vaccine rejection and hysteria about risk.

27 May 2011

Adalimumab plus methotrexate helps achieve higher levels of disease control in early RA

Data presented today at the EULAR 2011 Annual Congress demonstrated that initial treatment with adalimumab (Humira, ADA) plus methotrexate in early RA patients can provide high levels of disease control in many patients, and may also offer the opportunity to change future treatment options for some.

27 May 2011

Recent advances in vaccine development for malaria, TB and HIV/AIDS

Collectively, malaria, TB & HIV/AIDS cause more than five million deaths per year - nearly the entire population of the state of Washington - and represent one of the world's major public health challenges as we move into the second decade of the 21st century.

26 May 2011

PET scans can help determine patients' response to treatment for HIV-MDR tuberculosis

With the deficiencies in knowledge of tuberculosis-as well as in the practices, programs and strategies used to combat the disease and co-infection with human immunodeficiency virus-the spread of multidrug-resistant tuberculosis poses a major problem for the health care community.

25 May 2011

New findings from STELARA psoriasis clinical trial to be presented at 22nd World Congress of Dermatology

New findings to be presented from pooled analyses of the STELARA psoriasis clinical development program showed that the safety profile of STELARA and rates of adverse events remained consistent and stable over time in adults with moderate to severe plaque psoriasis receiving up to four years of treatment.

25 May 2011

Tuberculosis News and Research

Latest Tuberculosis News and Research

Therapeutic equivalent to replace penicillin

Stop TB partnership releases 5 TB prevention steps

Global Fund's transparency is essential and saves lives

International coalition launches common platform to end AIDS epidemic

Former Malian health minister indicted in case about misuse of global fund donations

International drug policy panel calls for legalization of some drugs, de-criminalizing drug use

Political engagement with China influences involvement in health

Mimicry allows bacteria to evade host's defense responses

Opinion: Integrate NTD, HIV, TB and malaria programs

New Kaiser Family Foundation tool shows which global health interventions are working

Experts to present latest information on paediatric infectious diseases at ESPID 2011

Media examine funding for HIV/AIDS as disease turns 30

AIDS epidemic turns 30

Novartis employees to do volunteer work for non-profit groups during 15th annual Community Partnership Day

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

Nature special issue focuses on vaccines

Adalimumab plus methotrexate helps achieve higher levels of disease control in early RA

Recent advances in vaccine development for malaria, TB and HIV/AIDS

PET scans can help determine patients' response to treatment for HIV-MDR tuberculosis

New findings from STELARA psoriasis clinical trial to be presented at 22nd World Congress of Dermatology

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in